CE

-medicalthrowaway-

bro, quit being the biggest ***S***quare in this ***P***la***CE***

Johnny_Menace

So many SP CE posts today, maybe it’s time for poots

No_Edge_7964

The SP(i)CE must flow

Scorch8482

If you bought SP CE at $6 ah you’re actually about to wake up to half your investment being deleted

Advanced-Guava9057

That would never happen to S (P) CE

Confident-Window4928

Who else is going to SP(A)CE with me?

random20190826

I sold lots of puts on CE, the chemical firm in Texas. I hope to avoid assignment if this holds.

netflix-ceo

CE O no he di'nt!

alemorg

The 1.7x claim. The 1994-to-present average is 1.82x. The current reading is 1.91x. That's the 79th percentile since the series started. The full range since 1994 is 1.55x to 2.06x: a 0.52x spread. You are off by 0.21x from the actual current number. That is 40% of the entire historical range. It is not "give or take a little." You pulled a number from memory years ago and presented it as fact while telling me you understand the data better. Step one to understanding data better than someone else: know what the number actually is. "U6 is structurally higher by design." Nobody said U-6 should equal U-3. The argument is that the gap is widening, from 3.7pp to 3.9pp in twelve months. That directional move, concurrent with temp help still down 21% from its March 2022 peak, quits at 2.0% (below the 2017-2019 average of 2.2%), and savings at 3.6%, is the signal. You keep arguing against a claim I never made. The Household Survey point. Yes, CE16OV civilian employment dropped from 163,992K in December 2025 to 162,622K in April 2026. That is 1.37 million fewer people employed in four months. U-3 held at 4.3% the whole time. That means people are exiting the labor force faster than jobs are being lost, which is precisely the denominator compression the post describes. You just handed me the cleanest illustration of my own argument. Thank you. You opened by calling the ratio \~1.7x constant. Wrong. You said I was being pedantic about the numbers. When the ratio is off by 40% of the historical range, that is not pedantry, that is your number being wrong. Then you pivoted to "U6 is structurally higher" like that addresses the widening gap. It doesn't. Then you conceded the deportation denominator issue, the savings rate, and real wages. Now you offer the Household Survey contraction, which cuts the same direction as everything else in the post. At some point "I agree with some of it" starts to look like the post was right and you had the ratio wrong from the jump.

DiversificationNoob

It took SpaceX around $390 million to develop Falcon 1 and Falcon 9 according to NASA.\* NASA has a budget of >$20 billion per year. So NASA easily had a proper budget to develop the SpaceX workhorse Falcon9. They would have had to reallocate less than 5% of ONE yearly budget \*"NASA independently verified SpaceX’s total development costs of both the Falcon 1 and Falcon 9 at approximately $390 million in the aggregate ($300 million for Falcon 9; $90 million for Falcon 1). NASA, *Falcon 9 Launch Vehicle NAFCOM Cost Estimates*, August 2011." [https://science.house.gov/\_cache/files/2/6/26810a9d-c6d7-4a7f-8be8-d0355d6c3903/E4FDDF4C21E1C120F8997C76D5EE89CCDFDB3EC7F5F2CE86E6A36C810A9615DA.102611-musk.pdf?utm\_source=chatgpt.com](https://science.house.gov/_cache/files/2/6/26810a9d-c6d7-4a7f-8be8-d0355d6c3903/E4FDDF4C21E1C120F8997C76D5EE89CCDFDB3EC7F5F2CE86E6A36C810A9615DA.102611-musk.pdf?utm_source=chatgpt.com)

DrawMeAPictureOfThis

Yes. America, founded in 1776, spread literacy to a country that invented paper in 105 CE. But... China's literacy rate was ~66% in 1982 and increased to over 97% by 2020.

bshtein

You couldn't possibly know it's going to be a winner. A lot of things aligned in certain way, like a demise of Symbian/Nokia, an unwillingness of then Microsoft management to innovate and move from a god-awful outdated Windows CE to a more advanced platform and other things. It could've wen the other way around too.

Stock-Estate-1667

What random post… 215CE has 59K OI… so will that be the potential target?

Travelingbunny20

It’s not the same. High speed rail is very resource heavy, expensive and centralized. AV is the opposite. It’s more obstacles like how to insure them, will traffic cops lose their jobs, will CE car companies give up their share, will the petroleum industry etc….

DesignerSea494

This week I went on a business trip to Seattle to do some recruiting for my company. We are looking for Engineers. This young guy came up to me and said he has a CE degree, but no one will hire him. I said, "You wont know unless you try. I believe in you. But I gotta tell you, we do drug test. You're pale, sweating, and keep scratching your face, so..."

netflix-ceo

When I read the news I was like CE O NO HE DI’NT

kobekillinu

Well, Lindt learnt the hard way in my country - EUR 8,99 was to expensive for most people in CE for a little chocolate bunny 🤯🤷‍♂️

AzureLainCapital

You do know microcap tickers generally have many previous management turn over ? In 2000 it was a different company Then 2010 different company different owners etc Txtm currently owners took over in 2022 where they took over previous owners company to forward his pharma biotech work Since 2022 they were handed a unfair CE that came off in 2025 but since then Wiped nearly all debts out , grew assets from $0 to $500m Perfected the previous management biotech kettle technology So no that’s a bad take to look at a full chart when they didn’t own the company for 85% of the tickers duration

staythewaters

"No one is investing huge amounts of capital into a country" I don't know where you've been in the last 25 years, but China doesn't need CE from other countries.

No_Pepper7348

Up 5 percent only due to buying HAL, CE, Dow chem and a couple of other oil holdings in the last 4 months.

DiarrheaFartLover

Meh, a 3 day chat ban wasn't worth it considering how little I type. https://www.leagueofgraphs.com/summoner/na/Tru%D0%BCps%20a%20p%CE%B5d%D0%BE%20xd-FILES

Jumpy-Boysenberry153

Imagine you're from an alien planet, reading a dispassionate history of this whole period, with the dramatis personae forgotten, just focusing on the stats. You read about Country A, which is the world's #1 oil producer. It shares its Medium Continent with world's #4 and #11 oil producers. All three countries are major exporters. On the other side of the world, in the northern part of the Big Continent, is the world's #3 oil producer, Country B. In 002022CE, Country B starts a war with its smaller neighbor; Country A supports that neighbor, dragging the war out, and eventually resulting in Country B's oil infrastructure getting bombed. As a result of that situation, major countries get removed from previously open financial standards; massive supply chains get boycotted by various coalitions; huge quantities of oil start getting sold on the "shadow market" for massive discounts. The "global market" and "global price" for oil fractures into many regional markets and prices. In the southern part of the Big Continent lies Waterway 1, which the world's #2, #6, #7, #8, #10, and #14 oil producers all rely on for export. In 002026CE, Country A bombs the hell out of the #6 producer, who then bombs the oil infrastructure of the other countries, and who then effectively shuts down Waterway 1. Country A then "gives up", leaving a trail of destruction in its wake. After reading this tale, you find yourself bemused at the footnote, that while all of this was happening, the earthling populace seemed to believe this was a total disaster for country A.

SheBenOnMyJohnson

Was CE, the bases I was deployed at are getting bombed glad I got out 😬

SheBenOnMyJohnson

Anything outside of CE, secfo and maintainer you’ll be fine

Yogurt_Up_My_Nose

https://www.bing.com/videos/riverview/relatedvideo?q=stank+twerk+wind&mid=894F5EE4B5741CE77E3D894F5EE4B5741CE77E3D&mmscn=stvo&FORM=VIRE

OrdinaryMix4013

I CE joining taxes in the most hated things ranking LMAO and this retard plans to send them to airports? how bad does this guy want to lose in Nov?

abroadbroadband

ÏCE agents being deployed to the airports to help with security huh That's fair. I've always thought security could take a little longer so I can ENJOY THE SCENERY GODDAMNIT WHY DOES HE KEEP DOING RANDOM SHIT LIKE THIS I ACTUALLY HAVE TO FLY EARLY MONDAY MORNING!!!!

Aldribuds

This kerfuffle will be called off if the Iranians just apologize to 🥭 for inventing the windmill in 700 CE

Possible-Shoulder940

[23 minutes ago](https://www.bloomberg.com/news/live-blog/2026-03-10/iran-war-trump-oil-markets-latest-news-updates?srnd=homepage-americas&cursorId=69AFF5CE49B80008) [25 minutes ago](https://www.bloomberg.com/news/live-blog/2026-03-10/iran-war-trump-oil-markets-latest-news-updates?srnd=homepage-americas&cursorId=69AFF53949F8004B)

wholewheatwithPB

Let’s start with everyone who voted for this regime. Those under 40 can be boots on the ground. Over 40 can be their battle commanders posting strategy on X/Facebook. I.CE is also a no brainer for conscription. Those who abstained from voting are next on the totem pole.

ReiShirouOfficial

“Dilution is possible” That’s possible with any company, you gotta trust management not to. This company promised so I take their word cause to me they have earned it https://preview.redd.it/i0sh8k6pjmmg1.jpeg?width=1290&format=pjpg&auto=webp&s=dfb415229787e09b7d2284dcf3a255e71eadb85c Why have they earned it? In the last 3 years under CE. Management cause like I said paid for everything out of pocket Taken no salary And never diluted under their management They have a Loi with another company truleaf that has passed assets into txtm also. So there is that Balance sheet continues to grow and scope of company continues to scale. No reason for me not to trust their words (even said in the press release) words from the ceo

Trippp2001

Oh, my sweet summer child. They’re a like a month away from the next time they’re CE or expert market or both.

ReiShirouOfficial

Factor in they contributed from the private entity via Loi 125 million miligrams of api aka less than 1 barrels worth https://preview.redd.it/dmsl761lvhmg1.jpeg?width=1290&format=pjpg&auto=webp&s=8da586640393d40c20ab2a7ffee792cccabca973 Then you got the chairmen himself saying It ain’t If. Referring to trailer(s) worth of barrels of business was done during the CE And it will make it onto the balance sheet Yeah I’d say the sales pipeline is immense At the very least worth more than a penny and the operation is way bigger than “magic seeds and accounting tricks”

Idaho1964

Make sure you know if there is any tax bill associated with this inheritance. Put that money aside now and let it grow at a modest rate: dividends + treasuries. Invest 50% in dividends + treasuries. 25% in US large caps 25% in International When there CE are sell offs truckle in some from that 50% pool.

Bichael-Murry

🅱️CE in 4 minutes

creamonyourcrop

So the entirety of last years gains was in January. I wonder what changed after January. https://fred.stlouisfed.org/series/CE16OV

ALMessenger

NVDA . . . puts What to buy? CE

Professional-Bad-559

According to Google: “The Colosseum was built between 70–80 CE by the Flavian dynasty emperors (Vespasian, Titus, and Domitian) as a massive public entertainment venue and a political tool to restore popular favor.” With all time low approval ratings, looks like he’s trying to gain some by death matches. I’m supposing it’ll be filled with the folks his SS troopers (aka. ICE) kidnaps.

Throwaway_Molasses

Nah, its valuation is bang on. Just barely under 3.0 price:book of 2.6 which is in value territory. But they are carrying 12B in debt MRQ. 10B cash and cash equivalent mrq which makes me wonder why are they carrying so much debt on the books compared to their cash and CE.

netflix-ceo

CE O No he di’nt

CBarkleysGolfSwing

[Tough question](https://i.imgur.com/8r1CE87.jpeg). [Maybe this will help you understand.](https://i.imgur.com/MXZxmg4.jpeg)

Informal-Taro9946

Bought $315 GOOGL CE expiry Jan 2027. Want to sell call for higher strike price with 30 or 60 day expiry using this long call. So basically a poor man’s covered call (PMCC).

HEK293INVAX

read all about it https://www.globenewswire.com/en/search/organization/NextNRG%CE%B4%2520Inc%C2%A7?page=1&\_gl=1\*1mrrqt6\*\_up\*MQ..\*\_ga\*NzIzMDc3MDE4LjE3NjY2MDM1Njc.\*\_ga\_ERWPGTJ5X8\*czE3NjY2MDM1NjckbzEkZzAkdDE3NjY2MDQzNzYkajYwJGwwJGgw

GoodIntroduction6344

Know fundamental analysis points, like ratios, e.g. forward P/E, D/E, etc., read financial news to gauge level of fear/hype propaganda pushed by private interests (what they want us to think), join interest groups to gauge retail sentiment, familiarize yourself with indicators, e.g., VIX, futures, short interest, money market yields, metals, etc., as well as historical seasonal impacts, earnings dates, price target adjustments, economy data dates, e.g., unemployment, jobs, inflation, CE, etc. Then gather the instruments you’ve collected into a passel and run them through technical analysis, e.g., chart patterns, candlestick patterns for entry/exit points, and know how to use TOS/Legend to scan for patterns and to set up other indicators, e.g., moving averages, vwap, etc., to achieve this with greater probability. Day trade within market hours to trade many instruments automatically with stop limits to mitigate losses. TP or loss every day and start again the next to keep from being a victim of after market economic impacts, next day impacts, earnings fallout, e.g., ORCL, buy in lot increments, e.g. 5K, 10k, etc., and diversify. Then stand back and lose your savings because of dark pools.

julian_jakobi

Indeed. Please see this great interview with Steve Harrison, CEO of Clyra Medical, and Dennis Calvert, CEO of BioLargo which updates everyone on the significant commercial activities underway and a few highlights the are worth noting. You can watch the interview here: https://www.youtube.com/watch?v=Zp1VRjV6Btg Notice a few highlights: * Sales commencing in the wound care industry ASAP with signing of advanced solution distribution agreement. * Surgical products in final stages of preparation for launch with industry-leading partner. * Clinical evidence underway with key opinion leaders and publication expected Q1. * International sales to begin ASAP subject to the completion of paperwork (already underway) for the CE mark required for sales in Europe, the Middle East, and Northern Africa. * Most recent capital inflow to Clyra at USD $100 Million valuation and BioLargo still owns 48% plus its royalty. * Products have a chance to become the “standard of care”. If you haven’t taken a look at the Clyra website in a while, be sure to notice the exceptional professionals who are surrounding the company and its products: https://www.clyramedical.com/advisoryboard

Intelligent_Hat_136

After we took resistance at 6790 at open I sold 6830 and when we got to 6770 I added a 6815 CE short(this fucked my day starting here) the sudden spike to 6815 set me back, I added another 6830 and 6825 and shorted 6800 PE and 6790 PE which again go fucked cause of the sudden drop, had to close the puts and rolled the calls down to 6780CE which again got run into. Man I couldn’t catch a break today. All these are with 20 wide hedges

AvocadoPurees

CE lectures blasting in the background, futures on 2nd screen, plugging away at work. Thanks AI for boosting my productivity

PerfectInAllThings

Bubbles in the Dresser Formation in Australia are 3.48 billion years old. By my calculations that suggests AI bubble could last at least until year 3,480,002,025 CE

Special_Economist803

Orcle CE holders account Washout 🤣🤣😂

WendyDumpsterFire

Bullish on Comcast next year: Broadcasting the FIFA World Cup next year, opening a new theme park in Texas, and also lots of new movies that will hit box office records. [Discussion I did in a different thread] (https://www.reddit.com/r/ValueInvesting/s/9qS1K7CE9h)

ThreeQuartersSerious

Not really insane, just obscure. The Dreamcast was a Windows CE machine, Microsoft was heavily involved in the hardware design, and most of sega’s dev teams pivoted to Xbox initially. For a good while in the early 2000s, there was strong belief that Microsoft was buying out sega’s entertainment business. Without Sega’s influence, the Xbox would’ve been a normal windows HTPC.

Krammsy

I don't know what I'm looking at, you're in a foreign market, I don't know what "PE" or "CE" stand for. You're better off describing it.

Icy_Bookkeeper_208

I'm sorry, Jon.  -  An AI generated Garfield gif uncovered among the ancient ruins. Circa 2025 CE.

TherealCarbunc

depends on the EU rollout. It got CE mark approval in June and has gotten $900k in orders so far that has been publicized. $400k from Spain and 900k from France. Positive signs it should started improving. it also partnered with the Carolina Fertility institute to offer FemaSeed. I have a feeling earnings may be better than I was initially expecting

ChristopherMiles21

Quest + CE data = legit combo, this could 5x on good feasibility read

ragnaroksunset

The entire point of DCA / buy and hold is that you don't give yourself the option to panic sell at the bottom because you stick to your purchasing plan. It's *designed* to overcome psychology. Once you introduce a decision point into the approach, you introduce a vector for psychology to enter back into the game. Then you get burned twice - once when you fail to time your divestment of the CE index, and again when you fail to time your re-entry - instead of zero times because you held through the drop and recovery.

Complex-Jello-2031

FemBloc is legit - CE marked in Europe (March 2025), approved in New Zealand (September 2025). The product works and addresses a real need. But you're right that U.S. FDA approval and meaningful revenue are 2-3 years out minimum. They just got FDA approval on November 3rd to continue their final trial phase (Part B), but that's just enrollment starting. Best case scenario you're looking at 2027-2028 for U.S. approval, and that's if everything goes perfectly. The bigger issue is the financing. They secured $12M in convertible notes with the trial news, but they're burning $4.5M per quarter with only $3.2M in cash. So more dilution is coming within 6-9 months. Current revenue is basically nothing - $409K last quarter. M&A potential is there eventually. At $36M market cap they're cheap enough for Bayer, Organon, or another women's health player to scoop up. But strategic buyers typically wait for FDA clarity. Nobody's paying a premium for a Phase 3 asset with years of trial risk and capital needs ahead. So yeah - legitimate science, real regulatory progress internationally, but the U.S. story and any M&A action is 2027+ if it materializes at all. The November 3rd pop already priced in the trial continuation news.

Complex-Jello-2031

You nailed it. That's exactly right. FemBloc is a real product with CE Mark in Europe and approval in New Zealand. But U.S. FDA approval is years away - they just got approval to start the final trial phase on November 3rd. Even if everything goes perfectly, you're looking at 2027-2028 for U.S. market entry. The cash situation is the real problem. They're burning through $4.5M per quarter and just raised $12M via convertible notes. That buys them maybe 6-9 months before they need more money, which means more dilution coming. M&A is possible down the road since the market cap is only $36M, but buyers will wait for more FDA clarity. Too much execution risk right now. But at this price point even if it does not work out you can usually still make money & they are not pure spec so the chances of collapse are minimal. Would a take a giant stake no but is it worth a small spec position Definitely. My key to these is buy the dips & trim 10% during the spikes that keeps your basis low & clears some risk

Aggressive-Bobcat-87

Massive news! Disruptive! 2.5 Mio pot. Interventionen just US with new patent up to 6 Mio Intervention just in the US End of 2026: MDR CE Approval, another pot. multimillion interventions TAM around 30 Billion in 2030

crunchsoop

I don't think that is his point. I think he sees the light. How in the shit balls can a $1.5t company pay a $1t pay package and have funds be excited about the prospects? Because their CE-bro tweets they "might" release a flying get. This shit is Ludacris. No offense to 90s hi hop.

stickman07738

DOW, CE and LYB are highly commoditized business with numerous competitor and as I stated ASH has been cleaning up and exiting their poor performing segments. I am waiting for ASH next quarterly report and expecting drastic improvements in gross profits.

MaleficentPositive53

ASH seems to be trading no differently than DOW, CE, LYB. The company seems to be facing the same sector risks.

Constant_Story8217

2026 and it's a remake of CE

logikok

Zinc is interesting because it has so much potential... But I've been reading that technically it's not there yet Taken from: https://www.sciencedirect.com/science/article/abs/pii/S0925838825000131 "Significant problems include zinc dendrites, the hydrogen evolution process (HER), and corrosion and passivation caused by the thermodynamic instability of the zinc anode. Low Coulombic Efficiency (CE) is caused by side reactions that deplete the electrolyte and zinc anode."

WaveZealousideal2848

I'm in both 

salty0waldo

There are a lot of factors causing this, and I think prior comments hit on the big ones. Commodity chemicals like PP and PE are in a massive oversupply with weak demand, think DOW/LYB/CE. Demand is an issue, but also China is dumping alot of cheap products into the market, which is putting strain on margins. Also, low oil prices hurt the margins. The industry was not prepared for such a prolonged downturn as well, so after a while the impact on the balance sheet became amplified (IMO). Specialty chemicals like DD, Corteva, EMN, and CC are expected to stabilize in Q3/Q4.

Future_Hyena2562

I was on a call last summer for CFP CE and they were pamping the hell out of gold. You think I would have been smart enough to listen.

NaluknengBalong_0918

Didn’t know they sell CE trim…

StreetAd3301

You missed the part, if you brought a stock for 1000$ today, and after 3 months it crashes to 600$ and then you sell covered call for 700 CE and unfortunately it expires deep ITM then you are forced to not only sell your stock at a loss of 400  but additionally also book loss on the sold deep ITM call option. There is no free lunch buddy !!

VastCar6051

"**Forget about it until it's on PubMed? It's already there.** You must not have done your search properly. Research papers related to the Lumee Oxygen Platform have been **officially indexed on PubMed Central (PMC)**, a part of the U.S. National Institutes of Health, since at least 2018. This proves that there is formal scientific literature available, not just a CE Mark. Furthermore, the reliability of this technology is already being validated in the clinic. The Lumee system is actively used by **Prof. Dr. Marianne Brodmann, the respected principal investigator for the Lumee Oxygen CE Mark studies**, in her own practice for approximately **1,500 vascular procedures annually**. A world-leading expert is confirming its critical clinical need. Finally, while you point out the lack of comprehensive CGM data, the **true value** of this technology lies in its **unparalleled long-term durability** and **market potential**. Standard CGM sensors like Abbott’s FreeStyle Libre are limited to **14 to 15 days**. In stark contrast, the Lumee hydrogel sensor is designed and shown to function for up to **two years** inside the body. This is a **unique technological advantage** only possible with an injectable sensor. Crucially, the glucose sensor (CGM) technology Profusa is developing targets a massive global market estimated at **₩15 trillion (approx. $11 billion)**. For context, **Abbott, the current CGM market leader, has a market cap exceeding ₩300 trillion (over $220 billion)**, yet Profusa, which owns this disruptive technology, is valued at **less than ₩20 billion (under $15 million)**. What we are discussing is not just a simple device, but the **dawn of a new era of 'bio-integrated sensors' that fully merge with the human body.** Instead of focusing on current clinical data figures, please look at the **bigger picture of human health innovation that Profusa is spearheading.** I am confident that it will surpass the growth trajectory of its competitor Abbott and even the early growth of **Nvidia**."

NikWih

Nice story, but they only claim to have a CE mark for Lumee Oxygen. They have no feets on the ground in Europe, they have no clinical data to back up their CGM story and WORSE - why are they not selling their oxygen measurement device? Maybe because there are already sufficient devices in the market and they do not get reimbursement? Just tell an agent to look until they put something up in [pubmed.gov](http://pubmed.gov) , but until then, straight up forget about this

PaperHandsTheDip

The only way I can think of to scale this is to hire a bunch of guys to manually input the shit for you. Crowdsource accounts and do arb between different accounts / names. You can obfuscate all your arbs if you have multiple people. Difficulty of figuring it out who is "in the group" and who isn't grows exponentially as people increase linearly due to combinations of accounts you can arb inbetween. For example - a group of 6 people may be enough to run a sophisticated arb operation on. We know bookies blacklist people / talk to each other (just like casinos) -- so you gotta be smart about it. For example - if you have 6 accounts / people, A,B,C,D,E,F. You arb between A (long) and B (short) on two different brokers. You can do the combinations AB AC AD AE AF \-- BC BD BE BF \-- CD CE CF \-- DE DF \-- Never run the arb between two accounts with the same name. This gives you 14 unique ways to run arbs while minimizing risk of getting caught. With 10 people you basically can run hundreds of arbs in different combinations. Obfuscation is one way to remain undetected.

Bittygirl707

$clov Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice # The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value October 15, 2025 08:30 ET  | Source: [Clover Health Investments, Corp.](https://www.globenewswire.com/en/search/organization/Clover%2520Health%2520Investments%CE%B4%2520Corp%C2%A7) [https://www.globenewswire.com/news-release/2025/10/15/3167077/0/en/Clover-Health-s-2026-Medicare-Advantage-Plans-Champion-Affordability-and-Choice.html](https://www.globenewswire.com/news-release/2025/10/15/3167077/0/en/Clover-Health-s-2026-Medicare-Advantage-Plans-Champion-Affordability-and-Choice.html)

Birkanugaris

[https://www.globenewswire.com/en/search/organization/Processa%2520Pharmaceuticals%CE%B4%2520Inc%C2%A7](https://www.globenewswire.com/en/search/organization/Processa%2520Pharmaceuticals%CE%B4%2520Inc%C2%A7) in 2mins, in 32mins or in 1hr2mins by most used time in their PRs

StocksRup-1

This list is excluding FEMY’s which has analyst targets exactly 10x current price. Currently trading at .65 and average analysts are $6 bucks with a high of $8. FEMY should be added based on current mkt cap and huge opportunity with a product mix already developed either CE marks globally with zero competitors

The_Brand94

I think what most people are missing here is that specialty chemicals and products companies like DOW, LYB, and CE produce will be used largely in the physical infrastructure build out for AI. 2026 likely to be a lower rate environment, construction picks up. I mean all these big tech companies are circle jerking money without much of the needed utilities and physical infrastructure being complete yet. They need land, buildings with most up to date materials/planning, and the draw they will put on the electrical grid. The physical construction portion of the build out for AI has really yet to be seen and I think we will see a lot more activity in 2026.

Bittygirl707

$CLOV Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant # New VP Blaine Lindsey to Drive National Enterprise Growth; Gulf Region President Shannon Jacobs to Scale Operations in High-Need Markets October 06, 2025 16:30 ET  | Source: [Clover Health Investments, Corp.](https://www.globenewswire.com/en/search/organization/Clover%2520Health%2520Investments%CE%B4%2520Corp%C2%A7) [https://www.globenewswire.com/news-release/2025/10/06/3162116/0/en/Counterpart-Health-Expands-Leadership-to-Accelerate-Enterprise-Partnerships-and-Regional-Adoption-of-AI-Powered-Platform-Counterpart-Assistant.html](https://www.globenewswire.com/news-release/2025/10/06/3162116/0/en/Counterpart-Health-Expands-Leadership-to-Accelerate-Enterprise-Partnerships-and-Regional-Adoption-of-AI-Powered-Platform-Counterpart-Assistant.html)

Tracen4justice

I have diabetes and I am using Libre3. Every 15 days I have to change the sensor which is always painful Additionally my arm is full of needle marks. The Libre3 delivers not always the correct values and so I have to do additional bloody measurements. I am just waiting for the CE permission and then, directly after it is available in Switzerland or Germany, I will take it. 365 days without the button on my arm, that's what I am really waiting for.

StocksRup-1

100% agree!!!!!! Discovered this stock in May 2024. The addressable market, approved CE, pending FDA, new funding. People will be sorry for missing this one.

Physical-Hall-2028

Get in as soon as possible.... In my opinion there will be a big squeeze soon given the hype it is generating. For the price at the end of the week I don't have a precise limit, think that this stock was at 1.89 and last February, it had dropped because it didn't have financing... Now that the financing for expansion and production has arrived, I would expect it to reach at least 1.5 dollars, and much more beyond that, given the recent developments (e.g. obtaining the CE mark and expansion into the European market). It is a microcap that is currently flying under the radar, analysts have price targets between $5 and $13, with an average of $5.67, and with "Strong buy" ratings. If they perform even in modest quantities, the potential upside could be enormous... However, do your own evaluations first.

Physical-Hall-2028

They are not a pump and dump, and FEMY is just starting its run..... Those who get in by the beginning of next week will have a big advantage. FEMY is flying under the radar. Among many things, this company has no competitors for non-surgical contraception, and has just begun to expand marketing of its Fembloc product, after obtaining the CE mark, in Europe. It has received recent commercialization funding. She recently published the positive results of her IVF test, Femaseed. The market is potentially huge. This stock was at 1.89 last February, and had dropped because it had no financing... Now that financing for expansion and production has arrived, I expect it to reach at least 2.5 dollars, or much more, given recent developments (e.g. expansion into the European market). Analysts have price targets between $5 and $13, averaging $5.67, with “Strong buy” ratings from brokerage firms.

StocksRup-1

This stock was at 1.80 on 2/20/25. It dipped down to a lack of funding. Not that funding has been secured, they have the time now to sell and increase revenues. Given their product mix and continuing CE approvals, I expect revenues will drive this to $2 in the short term based on valuation alone.

Neat-Excitement-53

I know we have our stocks for Next weak. But I want to bring attention to SENS.  I heard about it here and it seems they made the CE Mark submission on February, 2025 and the may be launch their product in Europe this year. Stock price seems decent 

netflix-ceo

CE Oh no he di'nt

ALMessenger

The idea that you buy a stock when people are pessimistic about it (and more likely to undervalue it) seems like a good starting point to me. I like a stock that is red on the 5 year chart. CE, CBRL, LULU, and ENPH are ones that I have high hopes for. You always need to be cautious though since there is no guarantee a company will not drop further (or even be around long term)

Mharciello

Never forget: https://www.reddit.com/r/wallstreetbets/s/DaD45Yw8CE

Natural_Flamingo9365

2019 The ReStore exo-suit for stroke rehabilitation received FDA & CE clearances for sale to rehabilitation clinics in the United States and within the European Union * 2020 Finalized agreements with key German payors for the supply of ReWalk Personal 6.0 to qualified patients; * Amended our research collaboration agreement with Harvard to focus on tele-health solutions and extend the term through March 2023; * Entering upper and lower extremity products, offering hand, leg, arm and balance systems with MediTouch * Adding functional electrical stimulation cycle for home and rehab therapy with Myolyn; and * The Centers for Medicare and Medicaid Services ("CMS") issued Healthcare Common Procedure Coding System ("HCPCS") Level II Code K1007 in response to the Company's application. This decision, which will be effective on October 1, 2020, establishes the first such code for exoskeletons. * Received Medicare Provider certification from the Centers for Medicare & Medicaid Services ("CMS"); * Completed additional contract with a German payor * Continued CMS progress made with issuance of HCPCS Level II Code for ReWalk Exoskeleton enabling an upcoming application for coverage 2021: The Company entered into a contract with BKK Mobile Oil health insurance to supply ReWalk’s Personal 6.0 System to eligible persons in Germany; Additional five BKK partners have joined the operating contract in Germany * Received FDA breakthrough device designation for ReBoot, a soft exoskeleton for stroke home and community use

pew_pew420420

Let's ride 

Ok-Albatross-3804

Possible recession on the table with rates cuts. Looking at recession proof stocks..$CERS According to Wall Street analysts, the average 1-year price target for CERS is 4.76 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD. Record Revenue: Cerus delivered record Q2 product revenue of $52.4 million, up 16% year-over-year, driven by strong demand for the INTERCEPT Fibrinogen Complex (IFC) and platelets. Guidance Raised: The company raised its full-year 2025 product revenue guidance to $200–$203 million (from $194–$200 million), with IFC sales outlook increased to $16–$18 million. IFC Momentum: IFC revenue nearly doubled quarter-over-quarter, and first-half IFC revenue almost surpassed all of 2024, reflecting greater hospital adoption and improved supply. Profitability Progress: Cerus achieved its fifth consecutive quarter of positive non-GAAP adjusted EBITDA, reporting $935,000 for Q2. Product Launches & Expansion: The new INT200 Illuminator launched in EMEA with positive customer feedback and regulatory approvals in multiple countries; CE Mark for red blood cell program in Europe expected in second half of 2026. Stable Margins: Gross margin remained steady at 55.2%, with management expecting margins to stay in the mid-50s for the balance of the year.

youlook_likeme

**Novocure** **Japan:** Novocure began NSCLC treatment in Japan after receiving regulatory approval on September 15, 2025. **Germany:** The launch and local availability of NSCLC treatment started in Germany earlier in 2025, following EU-wide CE Mark approval in April. **Spain:** Although covered by the EU-wide CE Mark since April, NSCLC treatment has not yet been launched or received public funding approval in Spain as of September 2025.  Also, two significant submissions with the FDA: **Pancreatic Cancer:** A Premarket Approval (PMA) application was submitted in August 2025 for its Optune Lua device for locally advanced pancreatic cancer, with an FDA decision expected in the second half of 2026. **Brain Metastases:** Based on positive results from the Phase 3 METIS trial, the company plans to submit a PMA application in the second half of 2025 for treating brain metastases from non-small cell lung cancer (NSCLC).

some_random_nonsense

It's not really my place to engage in pseudohistorical theorizing, but I would challenge one of the major examples in the quoted text: late Rome. The author here seems to be conflating a general idea that Rome was sexually libertine (when? it matters) with the eventual fall of the (likely) Western Roman Empire in the fifth century CE. And certainly there are some aspects here that are true. Romans of a certain class, after a certain point in the republic, did some freaky sex stuff. They also had lots of sex outside of marriage. Julius Caesar (d. 44 BCE), famously, had lots and lots of affairs. Emperors like Tiberius (d. 37 CE) and Nero (d. 69) were infamous for their sexual escapades and deviance. When we turn to a work of fiction, like Petronius' *Satyrica* (ca. 65 CE?), we find all sort of sexual libertinism. Like, tons of it. All sorts of weird combinations, stuff that would boggle your mind (and boggles students' minds today). Quick plug, here, for the Fellini *Satyricon* movie. It's weird, but so is the ancient text it's based on. And of course there's all the love poetry from guys like Catullus (d. 54 BCE), or Ovid's (d. 17/18 CE) *Ars Amatoria*. So yeah, the Romans, especially in the late Republic and early Imperial period, got up to some pretty freaky (and probably fun!) shit. They also did all sorts of horrible and awful things like systematically raping slaves and children (and child slaves) of both sexes, because that's what happens in a brutal slave society in which masculinity is deeply tied to the ability to penetrate (with swords, spears, or anything else). But they had been doing that for a loooong time: Amy Richlin's work on this is very good, as is Kathy Gaca's. And yes, eventually the Roman Empire fell. Not to get into the weeds on when, exactly, it fell (I think for all intents and purposes what happens after the 7th century CE is something totally new), but this person is most likely thinking of the Western Roman Empire, which collapsed over the middle decades of the fifth century CE, to be replaced by the "barbarian" successor states of the West. The canonical date for this, again all sorts of problems, is 476 CE. The main problem, here, is that the sexual libertinism of the Romans, which perhaps reached its peak in the first centuries of the common era, is... three or four or even five hundred years before the fall of the WRE. In fact, if you were to ask someone when the Roman Empire was at its height, it's when they were doing all the freaky stuff. You even have emperors like Hadrian (who is considered one of the best) who has a long term, very public homosexual relationship. Now, there is one major change having to do with sexuality that coincides with the fall of the Western Roman Empire: the rise of Christianity and the imposition of strict sexual norms against extramarital sex, homosexuality, and even in some cases against sex in general (the concept of holy virginity). Now, as a caveat, I don't think this has anything to do with the fall of the WRE, which has much more to do with transport costs, climate and environmental shifts, the incentive structures of the late Roman state, the rise of non-Roman confederacies, and a million things that have nothing to do with sex, but if you're a sex person, then you kind of have to wrestle with it. By the fifth century CE, the century in which the Empire collapses (in the West...), basically all of Roman society has converted to Christianity. With the rise of Christianity there is a new discourse that develops around the body, sin, desire, all that. Saint Paul, the most important figure in the development of Christian dogma, is famously ambivalent about sex, and the idea that sex should be restricted to marriage for procreation, if you're even going to have it, takes over. What we see in the decades leading up to the collapse of the West Roman state is in fact the total opposite of what the essay above argues. Rather than a period of sexual libertinism leading to imperial collapse, we find that the period of sexual libertinism is when the Empire is kicking ass and taking names. And it's the period in which there is a strict sexuality that denies non-procreative sex, or even sex in general, that sees imperial collapse. Again, I don't think these are related at all, but if you think that sex leads to the end of Empire, you can't use Rome as an example.

SecondSt4ge

Yeah I kinda have the same problem…servers have too many people that don’t help and I always get too much info or the wrong picks. Yeah I’m pretty deep into TXTM. I know some people that are already like 300% up because they got in before the CE ban lift. Once the ban lifted the stock jumped from 0.0001 to 0.005. That’s when I found out about it. It’s been fizzling down since then. But it’s still technically up. So I can’t say it’s doing bad. I just got in way too high and now price is dropping because there hasn’t been other major news the passed 2 months. I have about 2.65M shares at an avg around 0.0044

ReiShirouOfficial

My current play is txtm - Intent to retire in my 20s from it... Listen before judging this... https://preview.redd.it/v0b56v2v8knf1.png?width=689&format=png&auto=webp&s=eb47b070d4d3d70e55c028df11c0b6ceec90366f Q2 Assets doubled from 255m to 505m which by contract we are owed another 500m in assets thus doubling the balance sheet again. Paper wise we are trading at a 30m market cap with 505m+ in assets Waiting for PCAOB audit + sec reporting to be done at this moment. Backed by a prestigious chairmen who owns a farm half the size of paris which we will benefit from them soon A caveot emptor was removed so the only thing in the last 2 years was multiplying the balance sheet but ever since CE removal 3 months ago We learned we are finally hiring a PR firm / IR firm and advisory team People will bring up share structure but to get that out of the way, management has never diluted a share, and plan to uplist every share... Very great candidate for a long term buy and hold imo

______deleted__

“I hope I get the offer from IBM” said no talented CS/SWE/CE/AI graduate ever since the 2010s.

Roznadolina

If Liberty gets FDA approval, I honestly think MBOT could go way higher than people expect. We’re talking about the first remotely operated robotic system for endovascular procedures – that’s not just another “me-too” medtech, that’s a potential category creator. FDA approval would not only validate the technology but also open the doors to real hospital adoption in the US. From there, CE marking in Europe and approvals in other major markets (Japan, Middle East, LatAm) could follow. Each step would expand the TAM massively. Right now MBOT trades like a speculative microcap, but if Liberty proves itself clinically and commercially, you could easily see this rerating into small-mid cap territory over time. I don’t like throwing out exact numbers, but it’s not crazy to imagine multiples of the current market cap if adoption is successful. The real upside comes if Liberty establishes itself as a new standard of care in vascular robotics. That’s when you stop thinking in “hundreds of millions” and start thinking in “billions.” This is obviously high risk/high reward, but the potential runway here is enormous. If they execute, Liberty could take MBOT from being just another microcap ticker to a name everyone in medtech knows. 🚀

salty0waldo

Just wanted to add I was in DOW for a long time, terrible capital management that they are correcting. I exited prior to the previous quarter. I intend to re-enter this or next quarter. I am also eyeing LYB. A few other names are CC (refrigerant), EMN (vinyl), DD (speciality), CE (diverse)

ALQU1MISTA

I rather moved towards CE considering this year results. I would say that smaller companies will adapt better to current challenging conditions

salty0waldo

DOW and LYB are primarily commodities so polypropylene and polyethylene. They are hit hard by both tariffs and margin compression. CE, Westlake, and EMN have small commodity exposure. If the trough bottoms here, this is a nice base.

davewritescode

The magic has never been marketing, it’s been an impeccable sense of timing combined with nearly flawless technical execution. Apple has always been late to the game but when they enter a segment, they perfect it overnight. Portable MP3 players were a thing in the late 90s but the iPod was a revelation. Now instead of shuffling 10 songs onto a 128mb MP3 player I had my entire music library in my pocket. Same with the iPhone, nobody gave a shit about the bulky heavy Windows CE based phones or Sidekicks but when they iPhone came out it felt like a very viable useful product that made a real difference in day to day life. Microsoft had tablets in the early 2000s, but it wasn’t until the iPad came out that anyone cared about tablets. I have a feeling we’ll see history repeat itself here and it’s why I’m still a shareholder.

salty0waldo

Wow big gap down after reporting for CE, will have to dive in later. No positions here though, just following along.